Peptides by condition · Muscles, bones, joints and skin

Peptides studied for knee pain and osteoarthritis

Checked against our study pages and the FDA labelsPublished by PepVault

Our library holds 3 study pages on knee pain and osteoarthritis: 2 in people (1 of them a meta-analysis or randomized trial), and 1 in animals. They studied 3 compounds, with this many study pages each: Retatrutide 1, BPC-157 1 and AOD-9604 1.

What the research on knee pain and osteoarthritis looks like

Knee osteoarthritis is the slow wearing of the cartilage that cushions the knee joint, bringing pain and stiffness, and it grows more common with age and extra weight. The peptide evidence on knees is thin and mixed in kind: a weight-loss trial that also tracked knee pain, a look back at clinic records of knee injections, and an animal study of cartilage.

Knee studies in people use pain scores that the patient fills in, sometimes on a standard questionnaire. Animal studies look at the cartilage itself under a microscope.

Pain is easily swayed by expectation, so a result without a placebo group is weak evidence. Losing weight by itself eases knee pain, which matters when reading a weight-loss trial’s knee results.

Our study pages on knee pain and osteoarthritis by design: Trials in people 1, Other in people 1, Animals 1, Cells 0, of 3.Trials in people1Other in people1Animals1Cells0
How many of the 3 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.
A smiling man in a grey training top on a sofa with a foam roller beside him, his phone in his hands

Model. Individual results vary.

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The 3 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

  1. Retatrutide

    1 in people

    For knee pain and osteoarthritis, 1 of our study pages is filed under Retatrutide: 1 randomized trial in people. It enrolled 2,339 people and was published in 2026, in N Engl J Med.

    Retatrutide has no FDA-approved product: Drugs@FDA lists no application for it, and FDA writes that it is not a component of any FDA-approved drug.

  2. BPC-157

    1 in people

    For knee pain and osteoarthritis, 1 of our study pages is filed under BPC-157: 1 observational study in people. It enrolled 17 people and was published in 2021, in Altern Ther Health Med.

    BPC-157 has no FDA-approved product: Drugs@FDA lists no application for it.

  3. AOD-9604

    1 in animals

    For knee pain and osteoarthritis, 1 of our study pages is filed under AOD-9604: 1 animal study (rabbits). It was published in 2015, in Ann Clin Lab Sci.

    AOD-9604 has no FDA-approved product: Drugs@FDA lists no application for it.

Side by side

For the 3 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

CompoundIn peopleAnimals or cellsLargest in peopleFDA
Retatrutide102,339Not approved
BPC-1571017Not approved
AOD-960401—Not approved

What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

Questions

Which peptides have been studied for knee pain and osteoarthritis?

Our 3 study pages on knee pain and osteoarthritis are filed under 3 compounds, with this many each: Retatrutide 1, BPC-157 1 and AOD-9604 1. Retatrutide, BPC-157 and AOD-9604 have the most, 1 each.

Have any been tested in people with knee pain and osteoarthritis?

Yes: 2 of the 3 were in people, 1 of them a meta-analysis or randomized trial (Retatrutide). The largest enrolled 2,339 people: “Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1” (2026).

Is any peptide FDA-approved for knee pain and osteoarthritis?

Not by the labels our status pages read: of the 3 compounds here with an FDA record, none has a use tied to knee pain and osteoarthritis.

How large were the studies in people on knee pain and osteoarthritis?

Of the 2 in people, all give their size on our pages: 1 had 1,000 people or more and 1 had fewer than 100. The largest, a randomized trial from 2026, enrolled 2,339.

What did the animal and cell studies on knee pain and osteoarthritis use?

1 animal study (rabbits), filed under AOD-9604. A result in animals or cells shows what to test next, not what happens in a person.

What is the newest study on knee pain and osteoarthritis here?

Of our study pages on knee pain and osteoarthritis, the newest is “Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1”, a randomized trial in people published in 2026.

How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

Track it in the app

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo